---
$id: https://graph.org.ai/products/commodity/51384514
$type: Product
source: UNSPSC
code: "51384514"
title: "Naproxen"
class: "51384500"
classTitle: "Nonsteroidal anti inflammatory propionates"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Naproxen

**UNSPSC Code**: 51384514
**Class**: [Nonsteroidal anti inflammatory propionates](Nonsteroidal anti inflammatory propionates.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cyclooxygenase inhibitor with the molecular formula C14H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 57Y76R9ATQ, chemically known as 2-naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (s)- but generally known as naproxen, which bears US NIH Compound Identifier 1302. European Medicines Agency schedules Naproxen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09159MIG. The term NAPROXEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules naproxen in its Anatomical Therapeutic Chemical (ATC) Classification. NAPROXEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule naproxen under HS 29189900 and SITC 51396. As of Q4 2014, NAPROXEN remains the US FDA Preferred Term for this commodity. Naproxen bears US NLM identifiers UMLS ID C0700017 and NCI Concept Code C680. SMILES: O(C1CC2C(CC(C(C)C(=O)O)CC2)CC1)C.

